Publications
- splenic rupture from filgrastim.pdf
- chemohormonal rx in CANCER.pdf
- IFN IL2 hybrid for RCC.pdf
- The Breasts of Night.pdf
Failure to diagnose cancer and errors in treatment
Contact this Expert Witness
- Company: StarkOncologyConsulting, LLC
- Phone: 757-676-6354
- Cell: 757-676-6354
- Website: www.starkoncology.com
Specialties & Experience of this Expert Witness
General Specialties:
Oncology and HematologyKeywords/Search Terms:
Medical Malpractice, Failure to diagnose cancer, Improper cancer treatment, Product liability, Toxic Torts, Cancer causing agents, Patent InfringementEducation:
BA, Yale University; MD, Harvard Medical SchoolYears in Practice:
34Number of Times Deposed/Testified in Last 4 Yrs:
40Additional Information
Dr. Stark has a blue-ribbon top-tier Ivy League education: BA cum laude from Yale and MD cum laude from Harvard. He trained in Internal Medicine at Washington University/Barnes Hospital and returned to Harvard for a fellowship in Medical Oncology at the Dana Farber Cancer Institute. He practiced Hematology and Medical Oncology for 34 years and is currently Full Professor of Medicine at Eastern Virginia Medical School and a visiting lecturer at the University of Miami. He is board-certified in Internal Medicine and Medical Oncology for life, is a Fellow of the American College of Physicians, and a member of the American Society of Clinical Oncology. He has extensive experience as a litigation expert serving plaintiffs and defendants in equal numbers throughout the United States. He is considered an expert testifying witness making a good impression with juries. He is an editor of Practical Reviews in Cancer Management, a publication of Oakstone Publications, which produces continuing education materials for practicing physicians. He is on the editorial boards of numerous peer-reviewed medical journals. His recent litigation work continues to involve medical malpractice and other medical errors for plaintiffs and defendants, but he has become increasingly involved in toxic tort litigation, including such matters as the talc carcinogenesis litigation, the NDMA/Zantac carcinogenesis litigation, and the Philips CPAP litigation.